glp 1 and alzheimers GLP-1 drugs show promise in Alzheimer's treatment despite trial setback | Zain Khalpey, MD, PhD, FACS posted on the topic 𝐀 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐢𝐬𝐭'𝐬 𝐓𝐚𝐤𝐞 𝐨𝐧 𝐆𝐋𝐏-𝟏𝐬

A larger 3ml or 5ml syringe is perfect for accurately measuring and transferring the diluent into the peptide vial

Theres another big caveat, too: theres a lot of people who end up quitting these drugs after about two years

Ipamorelin was not among the peptides the committee reconsidered at its July 2026 meeting, so as of August 2026 that 2024 recommendation still stands

Complementary peptide options Advanced stacking approaches may incorporate additional peptides beyond the BPC-157/TB-500 foundation

While drug administration is straightforward, it may not be the right option for those who have a fear of needles